Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicera Therapeutics AB | 5,806,900 | net | 22 Jan 2026 | tx 9+5,806,900 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 Jan 2026 | LENDING | Elicera Therapeutics AB | 280,000 | 0.00 SEK | |
| 11 Mar 2025 | PURCHASE | Elicera Therapeutics AB | 43,211 | 1.85 SEK | first after silence |
| 14 May 2024 | LENDING | Elicera Therapeutics AB | 280,000 | 0.94 SEK | |
| 08 Mar 2024 | PURCHASE | Elicera Therapeutics AB | 6,173 | 16.20 SEK | first after silence |
| 07 Jul 2021 | OTHER | Elicera Therapeutics AB | 2,583,333 | 0.00 SEK | |
| 05 Jul 2021 | PURCHASE | Elicera Therapeutics AB | 12,100 | 4.30 SEK | |
| 10 Jun 2021 | LENDING | Elicera Therapeutics AB | 2,583,333 | 0.00 SEK | |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 9,375 | 0.00 SEK | deriv |
| 11 Jun 2021 | GRANT_AWARD | Elicera Therapeutics AB | 9,375 | 8.00 SEK |
2 purchases reported after at least 12 months of silence — most recent on 11 Mar 2025.